Nutriband Stock price
Is Nutriband a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Nutriband Stock Analysis
Analyst Opinions
7 Analysts have issued a Nutriband forecast:
Analyst Opinions
7 Analysts have issued a Nutriband forecast:
Don't miss a Thing! We will send you all news about Nutriband directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Nutriband Stock News
Company Profile
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2016 and is headquartered in Orlando, FL.
| Head office | United States |
| CEO | Mr. Sheridan |
| Employees | 13 |
| Founded | 2012 |
| Website | nutriband.com |


